Nu-Med Plus NUMD
OTC NUMD
$0.01 +0.00 (+13.33%)
As of: Nov 13, 2026 · 10:10 AM EST

Nu-Med Plus (NUMD) Return on Invested Capital [ROIC] (2017 - 2019)

Updated

Nu-Med Plus (NUMD) posted Return on Invested Capital [ROIC] of -922.71% for Q1 2019, down 606.04 percentage points from the prior quarter.

Analysis

Nu-Med Plus (NUMD) Return on Invested Capital [ROIC] (2017 - 2019) Analysis & Trends

For FY2018, Nu-Med Plus' Return on Invested Capital [ROIC] came in at -377.90%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 8.02%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 5.70%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 5.83%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 11.69%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 9.95%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 9.94%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 8.68%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 4.29%
10 Nu-Med Plus 835,484.67 823,182.67 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -922.71%
Dec 31, 2018 -316.67%
Sep 30, 2017 -196.81%
Jun 30, 2017 -455.62%
API Access

Nu-Med Plus Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NUMD&period=max&api_key=YOUR_API_KEY